Cell Signaling Technology

SignalSilence® Atg7 siRNA I

#6604 · $381

100
Citing papers
5.7k
Combined citations
Supplier page Find this product

Research areas

Autophagy in Disease and Therapy7Cancer-related molecular mechanisms research6Monoclonal and Polyclonal Antibodies Research5Glycosylation and Glycoproteins Research5Immune cells in cancer5Immune Cell Function and Interaction5Cytokine Signaling Pathways and Interactions5Cancer-related gene regulation4

Papers citing this product

1
Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures
The Lancet Respiratory Medicine·2020·541 cit.·DOI
2
An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A  Binding Properties Promotes Neuroprotection and Glial Engulfment of A 
Journal of Neuroscience·2012·309 cit.·DOI
3
SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis
Journal of Translational Medicine·2021·268 cit.·DOI
4
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Blood·2008·216 cit.·DOI
5
Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination
Autophagy·2013·206 cit.·DOI
6
TGF-β1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells
Cell Death and Disease·2020·200 cit.·DOI
7
A promising biodegradable magnesium alloy suitable for clinical vascular stent application
Scientific Reports·2017·167 cit.·DOI
8
Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury
Nature·2023·163 cit.·DOI
9
SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response
Cells·2021·124 cit.·DOI
10
The critical role of CD4+ T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma
Blood Advances·2020·121 cit.·DOI